Cellular energy / mitochondrial context
Substrate, cofactors and oxygen delivery behind ATP production.
WHOLE-CASE CLINICAL REASONING · PHYSIOLOGY → CELL
The reasoning layer between patient data and clinical judgment.
Cell-First connects labs, history, symptoms, medications, supplements and trends into one transparent physiologic story — showing supporting and contradictory evidence, compensation, upstream and downstream relationships, clinical blind spots, cellular bottlenecks, priorities and reassessment.
The loudest finding is rarely the cause. Work upstream.
No credit card required · Fictional demonstration data · De-identified-first workflow · Built for clinicians
More data is not the same as more understanding.
Labs, wearable data, supplements, medications, symptoms and patient history can all be present in the chart and still fail to answer the clinical question: how do these findings connect, what may be driving the case, what is compensatory, what does not fit, and what deserves attention first?
Cell-First does not stop at displaying results or drafting a plan. It organizes the reasoning between the data and the decision.
FROM SYSTEM TO CELL
From system-level findings to cellular bottlenecks.
Cell-First follows relevant physiology beyond organ-system labels into the biology that may be limiting function: cellular energy, mitochondrial substrate and cofactors, oxygen delivery, membrane and cellular signaling, inflammatory and oxidative tone, nutrient availability, recovery capacity, reserve and the cellular environment.
Membrane / cellular signaling
Membrane physiology, glycation, fatty-acid balance and signaling context.
Nutrient / cofactor function
Nutrients evaluated by physiologic role and pattern, not deficiency labels alone.
Terrain, recovery and reserve
Load, capacity, recovery and reserve held qualitatively — not as a simplistic score.
CLINICAL BLIND SPOTS
Sometimes the most important finding is what is missing.
Cell-First identifies missing information that could strengthen, challenge or materially change the current interpretation.
ILLUSTRATIVE FICTIONAL EXAMPLE
- BLIND SPOT
- Fasting insulin not available.
- WHY IT MATTERS
- Glucose and HbA1c alone may not characterize compensatory insulin output.
- QUESTION IT MAY ANSWER
- Is increased insulin production maintaining relatively normal glucose?
- POTENTIAL IMPACT
- The result could materially change metabolic prioritization.
INSIDE THE APPLICATION
The brief is the beginning. The reasoning is the product.
The case overview answers what matters first. Priorities & Support begins with the ranked decisions, then lets clinicians open the clinical sequence, support options, bottlenecks, sleep and medication context, and action checklist as needed. Each view reads from the same case without hiding the underlying detail.
Ordered by physiology
Priority follows where the physiology is limited, not the size of the flag.
Traceable to entered data
Every statement points back to the labs, medications, sleep and trends in the case.
Nothing withheld by category
Every option — nutrient, lifestyle or modality — is judged on this case. When one is held back, the reason and what would change it are stated.
OPEN A CASE
Read the brief, then look underneath it.
A fictional case, the way Cell-First presents it. Expand the brief to see the laboratory findings that carry the pattern, the medications and supplements already in play, and a verified trend that disagrees with the number.
CASE CF-DEMO01Age 52 · Female · fictional demonstration case
Case brief — what appears to be driving this case
Fasting glucose has only just crossed the reference ceiling and lipids are treated, yet fasting insulin is high and inflammatory tone is elevated. Two supplemented nutrients — magnesium and iron — are still below functional target, which points at delivery rather than dose. The most visible abnormalities on this panel sit downstream of insulin signaling and nutrient uptake.
What matters first: identify which absorption step is failing before changing any dose.
HOW CELL-FIRST REASONS THROUGH A CASE
Seven stages, in the order a clinician actually thinks.
01LISTEN
Start with the person, not the panel.
The complaint, the timeline, the thing the patient mentions on the way out the door — these decide which laboratory findings deserve weight. Cell-First keeps the story attached to the data instead of discarding it at intake.
THE PATIENT SAYS
“I fall asleep fine, but I’m awake at 3 a.m. and wired.”
ALSO IN THE CHART
Weight up 14 lb over two years, no change in diet.
THE PART USUALLY LOST
Afternoon energy crash, then a second wind at night.
None of this is a laboratory value. All of it changes how the laboratory values should be read.
Illustrative case language. Fictional data.
02CONNECT
Scattered findings usually belong to one physiology.
Reviewed one at a time, most of these values look unremarkable. Reviewed together, they describe a single mechanism under strain. Cell-First clusters findings before it interprets them.
- Fasting insulin 18
- Triglycerides 186
- HDL 41
- GGT 48
- hs-CRP 3.4
Supported interpretation
Compensatory hyperinsulinemia with hepatic lipid handling strain
Five findings, one physiology. Read individually, four of them look mild.
Illustrative example only — not diagnostic.
03CHALLENGE
A good interpretation has to survive the data that disagrees.
Contradictory findings are shown next to supporting ones, never smoothed over. When the evidence is thin, the case says so rather than manufacturing confidence.
Supports the pattern
- Elevated fasting insulin
- Elevated triglyceride/HDL ratio
- Rising GGT
Argues against it
- Normal HbA1c
- Normal waist circumference
- No hepatic steatosis on imaging
A normal HbA1c does not close the question. It may mean the compensation is still working — which is a different clinical situation than a case with no problem in it.
04TERRAIN
Two identical panels, two completely different bodies.
Terrain is how Cell-First holds that difference: what the system is carrying, what it can handle, how well it recovers, and how much margin remains. It is a reasoning frame, not a score.
LOAD
Elevated
What the system is being asked to carry.
CAPACITY
Adequate
The apparent ability to meet that demand.
RECOVERY
Reduced
Whether it restores itself between demands.
RESERVE
Insufficient data
How much margin appears to remain.
Terrain stays qualitative. Cell-First does not produce a terrain score, a 0–100 rating, or a “cellular age.”
05SEQUENCE
The most visible abnormality may be downstream from quieter physiology.
Systems may compensate for each other until they cannot. Cell-First helps separate what may be driving the case from what the body may be doing about it, and from the findings that show up downstream on the panel.
UPSTREAM
Impaired insulin signaling
Where the physiology appears to begin.
COMPENSATION
Sustained hyperinsulinemia
The body holding the line.
DOWNSTREAM
Lipid handling, inflammation, vascular burden
The loud part.
Focusing only on the downstream finding can leave the larger physiologic pattern unexplained. Illustrative example only.
06PRIORITIZE
Not everything deserves attention at once.
Findings are sequenced by safety, upstream position, supporting evidence, and likely systemic impact — so the visit has a defensible starting point rather than a list.
- 01Address immediate safety findingsSAFETY
- 02Restore metabolic signalingUPSTREAM
- 03Evaluate significant inflammatory driversCONNECTED
- 04Support cellular energy and cofactor adequacyFOUNDATIONAL
- 05Support membrane and cellular signalingFOUNDATIONAL
The hierarchy is dynamic — anemia, renal dysfunction, electrolyte disturbance, or medication toxicity can override the default sequence.
07REASSESS
Then ask whether the physiology actually moved.
Reassessment compares verified timepoints inside the same immutable Case ID. What improved, what did not, and what that disagreement implies about the original interpretation.
| MARKER | PRIOR | CURRENT | INTERPRETATION |
|---|---|---|---|
| Fasting insulin | 18.0 | 9.4 | ▼ Improving |
| Triglyceride / HDL | 4.5 | 2.6 | ▼ Improving |
| hs-CRP | 3.4 | 3.1 | ▼ Improving |
| GGT | 48 | 31 | ▼ Improving |
Metabolic and hepatic markers improved. hs-CRP is also improving because it moved toward the desired range; however, the change is modest and the value remains elevated, so the persistent inflammatory load still needs explanation.
Illustrative example only — fictional demonstration data.
WHAT CELL-FIRST ANALYZES
One case. 21 physiologic domains. One integrated view.
Metabolic / Insulin Signaling
Glucose regulation, insulin patterns, metabolic flexibility.
Inflammatory / Oxidative Signaling
Inflammatory markers read in metabolic and tissue context.
Cellular Energy / Mitochondrial
Substrate, cofactor and oxygen delivery behind ATP production.
Membrane / Cellular Signaling
Membrane physiology, glycation, fatty-acid balance.
Nutrient / Cofactor Status
Nutrients evaluated by function, not deficiency labels.
Thyroid / Neuroendocrine
Thyroid markers with nutrients, inflammation, medications.
Adrenal / Stress & HPA Response
Cortisol-driven effects on glucose, muscle, bone and sleep.
Hepatic / Biliary
Liver and biliary patterns within metabolic context.
Detoxification / Methylation & One-Carbon
Methylation capacity and the transsulfuration exit to glutathione.
Gut / Immune
GI symptoms, immune data, nutrient status, inflammation.
Histamine / Mast-Cell Activity
Histamine load weighed against clearance capacity.
Cardiovascular / Cardiometabolic
Lipoprotein burden, glucose physiology, vascular risk.
Hematologic / Iron & Oxygen Delivery
Red-cell indices, iron phenotype, and delivery to tissue.
Lymphatic / Immune Clearance
Clearance, immune traffic, and interstitial load.
Renal / Fluid, Electrolyte & Acid–Base
Filtration, hydration, electrolytes, and buffering reserve.
Purine / Urate Handling
Urate read as renal handling and ATP turnover, not diet alone.
Sleep / Circadian & Recovery
Sleep duration and timing carried through every affected system.
Endocannabinoid / Homeostatic Buffering
The restraint system linking stress, sleep, gut and pain findings.
Adipose / Storage Capacity
Storage capacity and adipokine signaling behind metabolic strain.
Genetic Context
Variants interpreted only against measured physiology.
Medication / Supplement Reconciliation
Duplicates, interactions, cumulative dosing, nutrient effects.
BUILT FROM DECADES OF CLINICAL EXPERIENCE
I kept seeing cases where the numbers were reviewed and the person was missed.
Values were flagged, each one addressed on its own, and nobody stopped to ask what the body was doing as a whole. The patient was still unwell, and the chart said everything had been handled.
Physiology does not work in isolated lines. Findings connect. Systems compensate for each other until they cannot. What shows up as the most visible abnormality may be a downstream expression of something quieter upstream — and focusing only on the downstream finding can leave the larger physiologic pattern unexplained.
It does not replace your judgment. It gives your judgment the whole picture to work with.
Cell-First Clinical Analysis™ was developed by Kelly Brink, PhD, DFM, DNM, DHM, a registered nurse with more than 34 years of clinical healthcare experience and professional training spanning functional, natural, and holistic medicine and health and wellness coaching.
Kelly developed the Cell-First framework to help clinicians move beyond isolated findings and understand how the patient/client story, laboratory data, physiology, biochemistry, adaptation, compensation, cellular environment, recovery capacity, and reserve may fit together.
The goal is to understand the physiology first, identify what matters most, follow relevant physiology to the cellular level when supported by the case, make uncertainty visible, and use better reasoning to guide the next clinical questions.
Kelly Brink, PhD, DFM, DNM, DHM
Founder & Clinical Framework Developer
Registered Nurse — 34+ years clinical healthcare experience
Certified Health & Wellness Coach
About the founderREPORTS
Turn complex analysis into something usable in the room.
Clinical Action Summary
A focused clinician-facing summary designed for rapid clinical review and documentation. Length adapts to case complexity while remaining concise and prioritized.
- Dominant physiologic pattern
- Safety / immediate concerns, when applicable
- Highest clinical priority and key secondary priorities
- Most important supporting findings
- Meaningful contradictory findings
- Clinical Blind Spots and decision-changing information
- What may be limiting restoration
- Immediate physiologic objectives and clinician-approved next steps
- What is not being prioritized right now
- Monitoring and reassessment considerations
- What Matters Now
Comprehensive Functional Case Review
An in-depth clinician report for the full clinical record and deeper case understanding.
- Patient story and relevant clinical context
- Measured and calculated findings
- All relevant physiologic domains
- Supporting and contradictory evidence
- Possible compensation and competing interpretations
- Upstream and downstream relationships
- Integrated Physiology Map
- Cellular Terrain: Load, Capacity, Recovery, and Reserve
- Clinical Blind Spots and decision-changing information
- Prioritization and phased roadmap
- Clinician-approved physiology-guided support
- Monitoring and reassessment plan
- Final Clinical Synthesis and What Matters Now
PATIENT / CLIENT REPORT
Patient / Client Understanding & Action Report
A clinician-reviewed, plain-language report designed to help the patient or client understand the major patterns, priorities, favorable findings, agreed support plan, and what will be reassessed.
It translates the clinical reasoning into clear educational language without presenting hypotheses as diagnoses or replacing appropriate medical care.
- Your story at a glance
- The main pattern we are paying attention to
- Understand the physiology
- What appears to be working well
- What deserves the most attention
- Other areas we are watching
- Safety / medical follow-up considerations
- What we are not chasing right now
- Your clinician-approved support plan
- What we will watch
- What would change our thinking
- What happens next
- Your case in plain language
AI DraftClinician ReviewedFinalizedClinician review remains central to the workflow.
Finalized reports can be downloaded as PDF, printed, or exported as an editable Word document.
FREE DEMO
Work a case from intake to report.
Explore a fully populated fictional case and follow the whole chain — the story, the connected findings, the contradictions, the terrain, the upstream driver, the blind spots, the prioritized support, and reassessment.
No credit card required • Fictional demonstration data
- A complete fictional case, intake through report
- Laboratory data, verified trends, and calculated markers
- A case brief that states what matters first
- Clinical Blind Spots and decision-changing information
- Sleep and medication physiology carried through the whole case
- Withheld options shown with the reason and what would change it
- Clinical Action Summary and comprehensive report
CLINICIAN ACCESS
Ready to analyze your own case?
Start with one case or choose a clinician plan based on your case volume and practice needs.
Cell-First brings clinical reasoning, physiology, prioritization, reassessment and reporting into one longitudinal clinician workflow.
Single Case
$49
One-time
For clinicians who want to experience one complete live case before subscribing.
- 1 complete longitudinal live case
- Whole-case clinical reasoning and physiology
- Prioritization, reassessment and reports for the same Case ID
- No subscription required
A low-risk way to experience the complete Cell-First workflow with a real case.
Clinician
Most popular$99/month
$990/year — approximately 2 months free
For most clinicians using Cell-First regularly in practice.
- 5 new cases / month
- Whole-case clinical reasoning and physiology
- Priorities, support guidance, reassessment & reports
- Follow-ups within the same Case ID included
- Unused monthly cases roll over for 60 days (up to 10)
- Additional new cases: $19 each
Clinician Pro
$179/month
$1,790/year — approximately 2 months free
For higher-volume clinicians managing a larger ongoing caseload.
- 15 new cases / month
- Everything in Clinician
- Designed for routine use across a larger caseload
- Follow-ups, reassessments and reports within existing Case IDs included
- Unused monthly cases roll over for 60 days (up to 30)
- Additional new cases: $14 each
Clinic
$349/month
$3,490/year — approximately 2 months free
For multi-clinician teams using Cell-First across a clinic.
- 3 clinician seats
- 30 new cases / month shared across the clinic
- Complete Cell-First reasoning, reassessment and reporting workflow
- Shared clinic case allocation
- Unused monthly cases roll over for 60 days (up to 60)
- Additional new cases: $10 each
- Additional clinician seats: $59/month
Everything included in a Cell-First case
Every case follows the same longitudinal reasoning workflow — from the patient story through physiology, prioritization and reporting.
- Whole-case integration
- Bring the patient/client story, history, laboratory data, medications and supplements, calculations, documents and relevant context into one reasoning framework.
- Clinical reasoning
- Connect patterns, relationships, competing explanations, contradictions and blind spots to understand what may matter most.
- Physiology → cell
- Follow relevant physiology through systems, signaling, biochemistry, cellular energy, membranes and the cellular environment when the case supports that depth.
- Priorities & support
- Understand what deserves attention first, why it matters, what biology may need support and what is not worth chasing right now.
- Reassessment
- Return to the same Case ID over time to compare what changed, what did not, and whether the original reasoning became stronger, weaker or needs revision.
- Professional reports
- Create clinician and patient/client communication from the reviewed case synthesis.
One case. One Case ID. Follow the physiology over time.
Follow-up labs, reassessments and reports within the same Case ID do not consume another new-case credit.
What counts as a new case?
A new case begins with a new Case ID. Follow-up information, reassessment and reporting for that same Case ID remain part of the existing longitudinal case and do not use another new-case credit.
Plan comparison
Single Case
- New cases
- 1
- Seats
- 1
- Follow-up / reassessment
- Included
- Clinician reports
- Included
- Patient/client reports
- Included
- Unused case rollover
- —
- Additional case price
- —
- Additional seats
- —
Clinician
- New cases
- 5 / month
- Seats
- 1
- Follow-up / reassessment
- Included
- Clinician reports
- Included
- Patient/client reports
- Included
- Unused case rollover
- 60 days, up to 10
- Additional case price
- $19
- Additional seats
- —
Clinician Pro
- New cases
- 15 / month
- Seats
- 1
- Follow-up / reassessment
- Included
- Clinician reports
- Included
- Patient/client reports
- Included
- Unused case rollover
- 60 days, up to 30
- Additional case price
- $14
- Additional seats
- —
Clinic
- New cases
- 30 / month shared
- Seats
- 3
- Follow-up / reassessment
- Included
- Clinician reports
- Included
- Patient/client reports
- Included
- Unused case rollover
- 60 days, up to 60
- Additional case price
- $10
- Additional seats
- $59/month
Not ready for a live case? Explore the fictional demonstration case first.
WHY CELL-FIRST
What makes Cell-First different?
| TRADITIONAL LAB-FLAGGING APPROACH | CELL-FIRST CLINICAL REASONING |
|---|---|
| Reference interval focus | Reference intervals + contextual clinician targets |
| A normal value ends the question | A normal value may reflect compensation |
| More tests | Information that could change the interpretation |
| One explanation | Competing interpretations, compared |
| One-time snapshot | Longitudinal reassessment |
| AI conclusion | AI-assisted analysis with clinician review |
A general conceptual comparison of approaches; no specific products or companies are described.
TRUST & SAFETY
Designed to support clinical judgment — not replace it.
Clinician Review
Generated analyses remain editable and reviewable before finalization.
Transparent Reasoning
Interpretations display supporting evidence, contradictory findings, and confidence.
Insufficient Data Means Insufficient Data
The system does not silently invent missing clinical information.
Safety First
Clinically significant safety findings take precedence over optimization recommendations.
Case-Based Architecture
Clinical information is organized by Case ID, never patient names.
Evidence and Uncertainty
Every interpretation is labeled measured, calculated, supported, or hypothesis.
CLINICIAN USE ONLY
- Not a diagnostic device. Does not diagnose disease.
- Does not prescribe medication.
- Does not replace clinician judgment.
- Does not replace emergency care or appropriate medical evaluation.
- Clinician review remains central before report finalization.
DE-IDENTIFIED-FIRST BY DESIGN
Cell-First is designed to work with non-identifying case information. The workflow uses Case IDs rather than patient names and does not require names, birth dates, medical record numbers, contact information or identifiable documents to reason through the current case structure.
Cell-First Clinical Analysis™ is an educational clinician reasoning and guidance platform. It does not diagnose disease, prescribe medication, provide medical treatment, or replace independent professional judgment or appropriate medical evaluation. Clinicians remain responsible for all clinical decisions and for operating within applicable professional scope and regulatory requirements.
FAQ
Questions clinicians ask.
See the case differently.
Explore a fictional case and see how Cell-First connects findings into a prioritized physiologic picture.
No credit card required • Fictional demonstration data • Clinician reasoning and educational guidance